Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma.

Halabi S, Rini B, Escudier B, Stadler WM, Small EJ. Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma. Cancer. 2014 Jan 01; 120(1):52-60.

View in: PubMed

subject areas

Aged
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Renal Cell
Clinical Trials, Phase III as Topic
Disease-Free Survival
Endpoint Determination
Female
Humans
Interferon-alpha
Kidney Neoplasms
Male
Middle Aged
Multivariate Analysis
Neoplasm Metastasis
Proportional Hazards Models
Prospective Studies
Randomized Controlled Trials as Topic
Survival Analysis

authors with profiles

Walter M. Stadler